Immucell (ICCC) Receivables - Other (2010 - 2026)
Immucell's (ICCC) quarterly Receivables - Other came in at $31177.0 in Q4 2025, down 23.12% YoY from $40555.0 in Q4 2024, and down 42.63% on a QoQ basis from $54341.0 in Q3 2025.
Immucell (ICCC) Receivables - Other (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Receivables - Other data on file, last reported at $31177.0 in Q4 2025.
- Quarterly Receivables - Other fell 23.12% year-over-year to $31177.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31177.0 (down 23.12% YoY) and the FY2025 annual result came in at $31177.0, down 23.12% from the prior year.
- Receivables - Other slipped to $31177.0 in Q4 2025, from $54341.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $250000.0 in Q3 2023 to a low of $15481.0 in Q3 2021.
- A 5-year average of $56500.8 and a median of $45669.5 in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2023 — Receivables - Other soared 651.07% — and 2024, when it sank 86.66%.
- Tracing ICCC's Receivables - Other over 5 years: stood at $55490.0 in 2021, then fell by 16.33% to $46426.0 in 2022, then dropped by 14.42% to $39733.0 in 2023, then increased by 2.07% to $40555.0 in 2024, then declined by 23.12% to $31177.0 in 2025.
- The last three Receivables - Other figures came in at $31177.0 (Q4 2025), $54341.0 (Q3 2025), and $44913.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,354.00 |
| Jun 30, 2026 | 6,354.00 |
| Dec 31, 2025 | 31,177.00 |
| Dec 31, 2025 | 31,177.00 |
| Sep 30, 2025 | 54,341.00 |
| Sep 30, 2025 | 54,341.00 |
| Jun 30, 2025 | 44,913.00 |
| Jun 30, 2025 | 44,913.00 |
| Mar 31, 2025 | 56,381.00 |
| Mar 31, 2025 | 56,381.00 |
| Dec 31, 2024 | 40,555.00 |
| Dec 31, 2024 | 40,555.00 |
| Sep 30, 2024 | 33,342.00 |
| Sep 30, 2024 | 33,342.00 |
| Jun 30, 2024 | 23,390.00 |
| Jun 30, 2024 | 23,390.00 |
| Mar 31, 2024 | 52,630.00 |
| Mar 31, 2024 | 52,630.00 |
| Dec 31, 2023 | 39,733.00 |
| Dec 31, 2023 | 39,733.00 |